The Influence of Vertical Implant Position With Immediate Provisionalization on the Marginal Bone Loss.
Launched by CAIRO UNIVERSITY · Aug 1, 2023
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking to understand how the depth at which dental implants are placed affects bone loss around the implant when a temporary tooth is added right away. Researchers want to find out if placing the implant deeper can help reduce bone loss, especially for patients with thin gum tissue. This is important because many people want their dental implants to look natural and stay healthy over time.
To participate in this study, you need to be an adult over 18 years old with a single missing tooth in the upper front or premolar area, and you should have enough healthy bone to support the implant. Good oral hygiene and a willingness to follow up for a year are also required. If you qualify and choose to participate, you can expect to receive a dental implant and temporary tooth as part of the study, while helping researchers learn more about improving implant success and appearance.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • ● Patients with single missing upper anterior or premolar teeth
- • Patients with minimum buccolingual width of 6 mm and mesiodistal width of 6mm
- • Patients with healthy systemic conditions.
- • Patients older than 18 years.
- • Good oral hygiene.
- • Accepts one year follow-up period (cooperative patients).
- • The patient provides informed consent.
- • Adequate Inter-arch space for implant placement.
- • Favorable occlusion (no traumatic occlusion).
- • Absence of allergy to the prescribed medications.
- Exclusion Criteria:
- • ● Patients with inadequate bone volume and/ or quality
- • Patients with local root remnants
- • Patients with inadequate wound healing
- • Patients with signs of acute infection related to the area of interest.
- • Patients with habits that may jeopardize the implant longevity and affect the results of the study such as parafunctional habits (Lobbezoo et al., 2006).
- • Heavy smokers patients (more than 10 cigarettes per day) (Lambert, Morris and Ochi, 2000).
- • Metabolic diseases such as diabetes or hyperthyroidism as well as systemic medications such as chemotherapy or bisphosphonates
- • Pregnant or nursing women.
- • Uncooperative patients.
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported